According to Mander [114], the available findings on the sleep-AD relation suggest that the pathological components of AD (i.e., Aβ, tau, neurodegeneration) are specifically associated with alterations in local and global expressions of sleep depending on the cerebral area affected. The gene discussed is MAPT; the disease is Alzheimer disease.